ALTAMIRA THERAPEUTICS LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.6 USD | +11.11% |
|
+13.15% | -54.02% |
Quotes 5-day view
End-of-day quote Nasdaq| 2024-04-22 | 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|---|
| Last | 1.4 $ | 1.58 $ | 1.44 $ | 1.6 $ | 1.69 $ |
| Volume | 107 242 | 110 808 | 3 000 617 | 322 810 | 166 284 |
| Change | -0.99% | +12.86% | -8.86% | +11.11% | +5.62% |
| Opening | 1.39 | 1.40 | 1.60 | 1.35 | 1.54 |
| High | 1.52 | 1.58 | 1.60 | 1.65 | 1.77 |
| Low | 1.38 | 1.38 | 1.40 | 1.35 | 1.50 |
Performance
| 1 day | +11.11% | ||
| 1 week | +13.15% | ||
| Current month | -22.71% | ||
| 1 month | -33.88% | ||
| 3 months | -20.00% | ||
| 6 months | -53.49% | ||
| Current year | -54.02% | ||
| 1 year | -92.31% | ||
| 3 years | -99.88% | ||
| 5 years | -99.93% |
Volumes
marketsDaily volume
319 994
Avg. Volume 20 sessions
309 398
Avg. Volume 20 sessions USD
495 036.80
Record volume 1
62 807 935
Record volume 2
16 486 219
Record volume 3
6 945 977
Capital turnover ratio
0.14
Float rotation
0.14
Basic data
Capitalization (USD)
3 786 014
Net sales (CHF)
0
Net sales (USD)
0
Number of employees
10
Sales / Employee (CHF)
0
Sales / Employee (USD)
0
Free-Float
99.11 %
Free-Float capitalization (USD)
3 752 214
Average Daily Capital Traded
14.3%
Highs and lows
1 week
1.35
1.77
1 month
1.352.49
Current year
1.353.60
1 year
1.3528.40
3 years
1.351 832.00
5 years
1.352 640.00
10 years
1.35636 800.00
Indicators
Moving average 5 days
1.49
Moving average 20 days
1.77
Moving average 50 days
1.85
Moving average 100 days
2.61
Price spread / (MMA5)
-6.88%
Price spread / (MMA20)
+10.62%
Price spread / (MMA50)
+15.62%
Price spread / (MMA100)
+63.12%
STIM
RSI 9 days
46.25
RSI 14 days
44.79
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +11.11% | +13.15% | -54.02% | -92.31% | 3.79M | ||
| -0.06% | +0.81% | -2.31% | +22.94% | 103B | ||
| -0.84% | -1.52% | +0.56% | +13.52% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +0.60% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -21.15% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.49% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -37.19% | 16.74B | ||
| +3.38% | +18.58% | -14.85% | -37.58% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +32.39% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +5.31% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -33.33% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +280.10% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +77.79% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +51.30% | 7.71B | ||
| +5.81% | +6.81% | -54.46% | -71.20% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +28.46% | 6.99B | ||
| Average | +1.83% | +4.60% | +7.94% | +11.89% | ||
| Weighted average by Cap. | +0.42% | +1.87% | +2.08% | +12.83% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -51.44% | ||
| 2023 | -96.41% | ||
| 2022 | -86.64% | ||
| 2021 | -30.73% | ||
| 2020 | +61.73% | ||
| 2019 | -82.24% | ||
| 2018 | -92.28% | ||
| 2017 | -44.81% | ||
| 2016 | -78.12% | ||
| 2015 | +25.38% | ||
| 2014 | -35.00% |
- Stock Market
- Equities
- CYTO Stock
- Quotes Altamira Therapeutics Ltd.
